propranolol has been researched along with Age-Related Osteoporosis in 12 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Excerpt | Relevance | Reference |
---|---|---|
"Based on this comparative study, the results strongly suggest that propranolol can be a candidate therapeutic drug for the management of postmenopausal osteoporosis." | 3.79 | Osteoprotective effect of propranolol in ovariectomized rats: a comparison with zoledronic acid and alfacalcidol. ( Bhat, MR; Khajuria, DK; Mahapatra, DR; Razdan, R, 2013) |
"The results provide no evidence that the beta-blocker propranolol may stimulate bone formation, and do not justify its use for clinical treatment of osteoporosis." | 3.74 | A trial study of propranolol and Zhigancao decoction on the central depressant and anti-osteoporosic action in ovariectomized rats. ( Guo, Y; Ishida, T; Kanehara, M; Murakami, T; Nakazawa, H; Takeda, A; Urata, S; Zhang, W; Zhang, Y, 2008) |
"Adults with hyperthyroidism have been found to have decreased bone mineral density (BMD) and higher fracture risk." | 1.91 | Graves' Disease in Children Presenting With Fragility Fracture: A Case Report. ( Liu, Y; Lyu, J; Sun, X; Wu, J; Yuan, C, 2023) |
"Osteoporosis is one of the major health problems in our modern world." | 1.33 | Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. ( Denhardt, DT; Ezura, Y; Karsenty, G; Kondo, H; Nakashima, K; Nifuji, A; Noda, M; Rittling, SR; Takeda, S, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (41.67) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Yuan, C | 1 |
Lyu, J | 1 |
Liu, Y | 1 |
Sun, X | 1 |
Wu, J | 1 |
Teong, B | 1 |
Kuo, SM | 1 |
Tsai, WH | 1 |
Ho, ML | 1 |
Chen, CH | 1 |
Huang, HH | 1 |
Chen, H | 2 |
Hu, B | 1 |
Lv, X | 1 |
Zhu, S | 1 |
Zhen, G | 1 |
Wan, M | 1 |
Jain, A | 1 |
Gao, B | 1 |
Chai, Y | 1 |
Yang, M | 1 |
Wang, X | 2 |
Deng, R | 1 |
Wang, L | 1 |
Cao, Y | 1 |
Ni, S | 1 |
Liu, S | 1 |
Yuan, W | 1 |
Dong, X | 1 |
Guan, Y | 1 |
Yang, H | 1 |
Cao, X | 1 |
Khajuria, DK | 1 |
Razdan, R | 1 |
Mahapatra, DR | 1 |
Bhat, MR | 1 |
Vignaux, G | 1 |
Ndong, JD | 1 |
Perrien, DS | 1 |
Elefteriou, F | 1 |
Folwarczna, J | 1 |
Pytlik, M | 1 |
Sliwiński, L | 1 |
Cegieła, U | 1 |
Nowińska, B | 1 |
Rajda, M | 1 |
Cock, TA | 1 |
Auwerx, J | 1 |
Kondo, H | 1 |
Nifuji, A | 1 |
Takeda, S | 1 |
Ezura, Y | 1 |
Rittling, SR | 1 |
Denhardt, DT | 1 |
Nakashima, K | 1 |
Karsenty, G | 1 |
Noda, M | 1 |
Levasseur, R | 1 |
Legrand, E | 1 |
Chappard, D | 1 |
Audran, M | 1 |
Zhang, W | 2 |
Kanehara, M | 2 |
Zhang, Y | 2 |
Ishida, T | 2 |
Guo, Y | 1 |
Urata, S | 1 |
Nakazawa, H | 1 |
Murakami, T | 1 |
Takeda, A | 1 |
Leroux, JL | 1 |
Mery, C | 1 |
Amor, B | 1 |
Lemaigre, G | 1 |
1 review available for propranolol and Age-Related Osteoporosis
Article | Year |
---|---|
Leptin: cutting the fat off the bone.
Topics: Adrenergic beta-Antagonists; Animals; Bone Density; Energy Metabolism; Humans; Hypothalamus; Leptin; | 2003 |
11 other studies available for propranolol and Age-Related Osteoporosis
Article | Year |
---|---|
Graves' Disease in Children Presenting With Fragility Fracture: A Case Report.
Topics: Adult; Child; Female; Graves Disease; Humans; Hyperthyroidism; Infant; Methimazole; Osteoporosis; Pr | 2023 |
Liposomal Encapsulation for Systemic Delivery of Propranolol via Transdermal Iontophoresis Improves Bone Microarchitecture in Ovariectomized Rats.
Topics: Administration, Cutaneous; Animals; Blood Urea Nitrogen; Bone and Bones; Bone Density; Calcium; Chol | 2017 |
Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis.
Topics: Adrenergic beta-Antagonists; Adrenergic Fibers; Animals; Bone and Bones; Bone Density; Bone Regenera | 2019 |
Osteoprotective effect of propranolol in ovariectomized rats: a comparison with zoledronic acid and alfacalcidol.
Topics: Adrenergic beta-Antagonists; Animals; Bone Density Conservation Agents; Diphosphonates; Female; Hydr | 2013 |
Inner Ear Vestibular Signals Regulate Bone Remodeling via the Sympathetic Nervous System.
Topics: Animals; Bone Remodeling; Female; Mice; Mice, Knockout; Osteoblasts; Osteoporosis; Propranolol; Symp | 2015 |
Effects of propranolol on the development of glucocorticoid-induced osteoporosis in male rats.
Topics: Adrenergic beta-Antagonists; Animals; Bone and Bones; Bone Density; Glucocorticoids; Male; Osteoporo | 2011 |
Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system.
Topics: Amino Acids; Animals; Biomarkers; Body Weight; Bone and Bones; Bone Marrow Cells; Dopamine beta-Hydr | 2005 |
Central control of bone mass: potential therapeutic implications.
Topics: Adrenergic beta-Antagonists; Bone and Bones; Bone Density; Humans; Leptin; Osteoporosis; Propranolol | 2005 |
Beta-blocker and other analogous treatments that affect bone mass and sympathetic nerve activity in ovariectomized rats.
Topics: Acupuncture Therapy; Adrenergic beta-Antagonists; Animals; Blood Pressure; Body Weight; Bone and Bon | 2007 |
A trial study of propranolol and Zhigancao decoction on the central depressant and anti-osteoporosic action in ovariectomized rats.
Topics: Adrenergic beta-Antagonists; Animals; Bone Density; Disease Models, Animal; Drugs, Chinese Herbal; F | 2008 |
[Hyperthyroid fibrocystic osteitis].
Topics: Female; Femur; Humans; Hypercalcemia; Hyperthyroidism; Mandible; Middle Aged; Osteitis Fibrosa Cysti | 1981 |